Singlera Genomics Incorporated

Singlera Genomics is a developer of liquid biopsy analysis reagents and software, focusing on determing methylation haplotypes across many thousands of genomic locations in cell-free DNA. Singleras PanSeer assay can detect cancer four years before conventional diagnosis through a sophisticated but easily implemented targeted methylation assay and efficient bioinformatics analysis. Singleras ColonES assay has high sensitivity (over 97% for CRC Stg I and 91% for advanced adenomas) and very high specificity (99% for healthy individuals). Currently pre-commercial, Singlera welcomes contact from potential collaborators to bring this revolutionary technology to market

Liquid biopsy,cell-free dna,methylation haplotyping,assay development,ngs,and molecular diagnostics

Singlera genomics incorporated operates in the Biotechnology research industry.

Singlera genomics incorporated's revenue is 11m - 100m

Singlera genomics incorporated has 11 - 50 employees.